SOC vs hydroxychloroquine vs hydroxychloroquine plus azithromycin for clinically declining non-critical COVID-19

Phase 4, randomised trial in coronavirus disease 2019 (COVID-19) comparing Standard of care, Plaquenil plus standard of care and Plaquenil plus azithromycin plus standard of care (3 arms). Primary endpoint: Composite primary endpoint. Started Apr 2020; status: terminated.